Drug intelligence / Profile preview

insulin + levothyroxine

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes, Peptides, Small Molecules
Administration
Subcutaneous, Intravenous, Oral, Intramuscular
01

Overview

This is a combination of two drugs, insulin and levothyroxine. Insulin is a peptide hormone used to regulate blood glucose levels in patients with diabetes mellitus by promoting cellular uptake of glucose, inhibiting hepatic glucose production, and modulating fat and protein metabolism. Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4), used as replacement therapy in hypothyroidism to restore normal metabolic activity by supplementing deficient endogenous thyroid hormone levels. There are no known fixed-dose combination products containing both insulin and levothyroxine; they are typically prescribed separately for comorbid diabetes mellitus and hypothyroidism. Both drugs have distinct mechanisms of action—insulin acts on the insulin receptor to facilitate glucose uptake, while levothyroxine acts as an agonist at nuclear thyroid hormone receptors to regulate gene expression involved in metabolism[1][3][7]. Coadministration may require dose adjustments due to potential pharmacodynamic interactions affecting glycemic control[5].

02

Targets

THRB (Thyroid hormone receptor beta)INSR (Insulin receptor)THRA (Thyroid hormone receptor alpha)

Beyond the preview

Go deeper on insulin + levothyroxine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on insulin + levothyroxine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call